Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Feasibility Study of Hexvix Photodynamic Therapy in Patients With Intermediate or High-risk Bladder Cancer

NCT01303991 is registered in ClinicalTrials.gov with Photocure as lead sponsor.

NCT NCT01303991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Feasibility Study of Hexvix Photodynamic Therapy in Patients With Intermediate or High-risk Bladder Cancer
Lead sponsor
Photocure
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2005
Completion date
August 31, 2008
Enrollment
17 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

intermediate or high-risk bladder cancer